Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies (2017)
- Authors:
- USP affiliated authors: SANTOS, RAFAEL GUIMARÃES DOS - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP
- Unidade: FMRP
- DOI: 10.1016/B978-0-12-800756-3.00094-6
- Subjects: CANNABIS; EPILEPSIA; ANSIEDADE; ANTICONVULSIVANTES
- Language: Inglês
- Imprenta:
- Source:
- Título: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment
- Volume/Número/Paginação/Ano: 1143 p.
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
SANTOS, Rafael Guimarães dos et al. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies. Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. Tradução . London: Elsevier, 2017. p. 1143 . Disponível em: https://doi.org/10.1016/B978-0-12-800756-3.00094-6. Acesso em: 11 fev. 2026. -
APA
Santos, R. G. dos, Hallak, J. E. C., Zuardi, A. W., Crippa, A. C. de S., & Crippa, J. A. de S. (2017). Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies. In Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment (p. 1143 ). London: Elsevier. doi:10.1016/B978-0-12-800756-3.00094-6 -
NLM
Santos RG dos, Hallak JEC, Zuardi AW, Crippa AC de S, Crippa JA de S. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00094-6 -
Vancouver
Santos RG dos, Hallak JEC, Zuardi AW, Crippa AC de S, Crippa JA de S. Cannabidiol for the treatment of epilepsy: an overview of possible mechanisms of action and preclinical and human studies [Internet]. In: Handbook of Cannabis and related pathologies: biology, pharmacology, diagnosis, and treatment. London: Elsevier; 2017. p. 1143 .[citado 2026 fev. 11 ] Available from: https://doi.org/10.1016/B978-0-12-800756-3.00094-6 - Cannabidiol for the treatment of drug use disorders
- Neuropharmacological effects of the main phytocannabinoids: a narrative review
- O uso do canabidiol (CBD) no tratamento da doença de Parkinson e suas comorbidades
- Modulation of the endocannabinoid and oxytocinergic systems as a potential treatment approach for social anxiety disorder
- Cannabidiol and neuroprotection: evidence from preclinical studies
- Cannabidiol displays proteomic similarities to antipsychotics in cuprizone-exposed human oligodendrocytic cell line MO3.13
- Marijuana, feijoada and the debate on drug legalization
- Cannabidiol for the treatment of psychosis in Parkinson's disease
- Δ9-THC intoxication by cannabidiol-enriched cannabis extract in two children with refractory epilepsy: full remission after switching to purified cannabidiol
- Administration of harmine and imipramine alters creatine kinase and mitochondrial respiratory chain activities in the rat brain
Informações sobre o DOI: 10.1016/B978-0-12-800756-3.00094-6 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
